2. Repository of UKIM
  3. Faculty of Medicine
  4. Faculty of Medicine: Journal Articles

Repository of UKIM


Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/18445
DC FieldValueLanguage
dc.contributor.authorBuklioska Ilievska, Danielaen_US
dc.contributor.authorMinov, Jordanen_US
dc.contributor.authorKochovska-Kamchevska, Nadeen_US
dc.contributor.authorGigovska, Irenaen_US
dc.contributor.authorDoneva, Anaen_US
dc.contributor.authorBaloski, Marjanen_US
dc.date.accessioned2022-06-09T07:49:20Z-
dc.date.available2022-06-09T07:49:20Z-
dc.date.issued2019-07-15-
dc.identifier.citationBuklioska-Ilievska D, Minov J, Kochovska-Kamchevska N, Gigovska I, Doneva A, Baloski M. Carotid Artery Disease and Lower Extremities Artery Disease in Patients with Chronic Obstructive Pulmonary Disease. OAMJMS [Internet]. 2019Jul.18 [cited 2019Sep.22];7(13):2102-7.en_US
dc.identifier.issn1857-9655-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/18445-
dc.description.abstractTo assess the frequency of carotid artery disease (CAD) and lower extremities artery disease (LEAD) in patients with chronic obstructive pulmonary disease (COPD) and their relation to the severity of airflow limitation and the level of C-reactive protein (CRP).en_US
dc.language.isoenen_US
dc.publisherScientific Foundation SPIROSKIen_US
dc.relation.ispartofOpen Access Macedonian Journal of Medical Sciencesen_US
dc.subjectAirflow limitationen_US
dc.subjectC-reactive proteinen_US
dc.subjectCarotid arteryen_US
dc.subjectDoppler ultrasonographyen_US
dc.subjectLower limb arteriesen_US
dc.titleCarotid Artery Disease and Lower Extremities Artery Disease in Patients with Chronic Obstructive Pulmonary Diseaseen_US
dc.typeArticleen_US
dc.identifier.doi10.3889/oamjms.2019.576-
dc.identifier.urlhttps://spiroski.migration.publicknowledgeproject.org/index.php/mjms/article/download/oamjms.2019.576/3588-
dc.identifier.urlhttps://spiroski.migration.publicknowledgeproject.org/index.php/mjms/article/download/oamjms.2019.576/3548-
dc.identifier.volume7-
dc.identifier.issue13-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
Carotid_Artery_Disease_and_Lower_Extremities_Arter (1).pdfAIM: To assess the frequency of carotid artery disease (CAD) and lower extremities artery disease (LEAD) in patients with chronic obstructive pulmonary disease (COPD) and their relation to the severity of airflow limitation and the level of C-reactive protein (CRP). METHODS: We performed a cross-sectional study including 60 patients with COPD (52 male, 8 female), aged 40 to 80 years, initially diagnosed according to the actual criteria. Also, 30 subjects in whom COPD was excluded, matched to COPD patients by sex, age, body mass index and smoking status, served as controls. All study subjects completed questionnaire and underwent pulmonary evaluation (dyspnea severity assessment, baseline and post-bronchodilator spirometry, gas analyses, and chest X-ray), angiological evaluation by Doppler ultrasonography and measurement of serum CRP level. RESULTS: We found a statistically significant difference between the frequency of carotid plaques in COPD patients as compared to their frequency in controls (65% vs 30%; P = 0.002). The mean value of intima-media thickness (IMT) in COPD patients with CAD was significantly higher than its mean value in controls (0.8 ± 0.2 vs. 0.7 ± 0.2; P = 0.049). IMT value in COPD patients with CAD was significantly related to the degree of airflow limitation, i.e. to the degree of FEV1 decline (P = 0.000), as well as to the serum CRP level (P = 0.001). We found a statistically significant difference between the frequency of COPD patients with LEAD as compared to the frequency of LEAD in controls (78.3% vs 43.3%; P = 0.001). According to the Fontaine classification, COPD patients with LEAD were categorized in the stages I, IIA and IIB (53.3%, 30% and 16.7%, respectively), whereas all controls with LEAD were categorized in the Fontaine stage I. Among COPD patients with LEAD there was significant association between disease severity and clinical manifestations due to the vascular changes (P = 0.001) and serum CRP level (P = 0.001). CONCLUSION: Our findings suggest higher prevalence and higher severity of vascular changes in COPD patients as compared to their prevalence and severity in non-COPD subjects. Prevalence and severity of vascular changes in COPD patients were significantly related to the severity of airflow limitation and serum CRP levels.214.81 kBAdobe PDFView/Open
Show simple item record

Page view(s)

44
checked on Apr 28, 2024

Download(s)

6
checked on Apr 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.